Received May 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
he nearly died; This serious case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Additional patient notes included patient other products and other conditions were not provided. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced near death experience (Verbatim: he nearly died) (serious criteria GSK medically significant). The outcome of the near-death experience was unknown. It was unknown if the reporter considered the near-death experience to be related to Shingrix. The company considered the near-death experience to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 17-MAY-2026 The reporter reported that son received that shot and patient nearly died. The patient mother would not have advised anyone to get it. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Near-death experience, unknown time after receiving Shingrix in a male patient. Case lacks further information on time to onset, medical history, concurrent conditions. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.
Comments: patient other products and other conditions were not provided